Christopher Yea - CHIEF DEVELOPMENT OFFICER at KalVista Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Development Officer
Stock Symbol
KALV on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Christopher Yea - trading volume in the past year for KalVista Pharmaceuticals, Inc.

Holdings reported by Christopher Yea for KalVista Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 85.7K $1.06M $12.40 Aug 23, 2024 Direct
Restricted Stock Units 50K $588K $11.76 May 22, 2024 Direct Common Stock
Restricted Stock Unit 46.9K $563K $12.01 Aug 22, 2024 Direct Common Stock
Performance Stock Units 7.29K $84.1K $11.53 Aug 17, 2024 Direct Common Stock
Performance Stock Unit 0 $8.23 Nov 17, 2023 Direct Common Stock

Transactions reported by Christopher Yea for KalVista Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.